A lose-lose situation?

There are currently 15 SEF applications lodged with the US CTFC at various stages of registration. With experience in other asset classes showing that while many new entrants may emerge only a few will succeed, many in the industry are wondering which of these new SEFs will make it beyond their first birthday.

Even for those that do survive there’s no guarantee of a profitable business at the end of it. The CFTC’s MAT rule (Make Available to Trade) states that once a SEF makes a swap available to trade, all other SEFs and DCMs listing the same swap have to make it available to trade too. So the more successful a specific swap becomes the greater the likelihood that a SEF will face competitive undercutting of its fees. A lose-lose situation for the SEF, surely.

On the one hand the MAT rule is good news for investors and traders but on the other hand it raises questions about innovation. In the pharmaceuticals industry, a patents system incentivises investment in research and development. In the swaps market no such mechanism exists to support investment in new ideas. In deciding how and when to apply the MAT rule, the CFTC needs to strike a balance between competition and innovation – and that is certainly no easy task.

Leave A Comment

Copyright © 2017 Fidessa group plc. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.